U.S. Markets close in 3 hrs 30 mins

Allergan plc (AGN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
218.19-3.35 (-1.51%)
As of 12:30PM EDT. Market open.
People also watch
Full screen
Previous Close221.54
Bid218.67 x 100
Ask218.75 x 100
Day's Range217.11 - 223.04
52 Week Range184.50 - 256.80
Avg. Volume2,001,987
Market Cap72.94B
PE Ratio (TTM)6.65
Earnings DateN/A
Dividend & Yield2.80 (1.27%)
Ex-Dividend Date2017-08-16
1y Target EstN/A
Trade prices are not sourced from all markets
  • Should Value Investors Consider Allergan plc (AGN) Stock Now?
    Zacks3 hours ago

    Should Value Investors Consider Allergan plc (AGN) Stock Now?

    Is Allergan (AGN) a great pick from the value investor's perspective right now? Read on to know more.

  • Barrons.comyesterday

    Why Allergan Could Be A $300 Stock

    Shares of Allergan (AGN) are rising today after J.P. Morgan analyst Chris Schott said the drug maker’s stock could climb more than 30% in the next year. Allergan’s share price has fallen more than 12% since it hit a 52-week high of $256.80 in late July. Overall, we believe several controversies (most notably the timing of generic Restasis competition) have taken focus away from a highly attractive core franchise at Allergan and as we look out to 2018, we see an increasingly compelling setup for AGN shares with both pipeline optionality and a strong SOTP valuation argument.

  • TheStreet.com3 days ago

    Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

    Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack.